Two large-scale employer health surveys landed ten days apart in August, run by different organizations with different methodologies, and they arrived at nearly the same number. Aon says U.S. employer health costs will rise 9.5% in 2027. The Business Group on Health (BGH) says 9.2%. Trade press covered both, but not as one story, and read together the coverage says something neither survey states on its own: the era of blaming a single bad year for health cost spikes is over, and HR and benefits leaders are being pushed into a posture shift that goes well beyond the annual renewal cycle.
Two Surveys, Ten Days Apart
Aon published its projection first, on Aug. 20, drawing on its Health Value Initiative database of more than 1,100 U.S. employers and 7.9 million employees. Costs are projected to climb 9.5% before mitigation, pushing average total employee health spending above $19,000 for 2027, the fourth consecutive year of increases approaching double digits. Days later, BGH released its own Employer Health Care Strategy Survey, drawn from 127 large employers covering 8.7 million people in the U.S., putting the 2027 figure at a median 9.2% before plan design changes, or roughly 8% after them.
Neither number is new in isolation. What is new is that two independently run surveys, using different employer samples and different methodologies, converged within half a percentage point of each other in the same two-week window, both describing a fourth straight year of near-double-digit growth. That convergence is the part the underlying press releases cannot say about themselves, because each only speaks to its own data.
“Employers have now experienced several consecutive years of health care cost increases that are approaching double digits,” said Mike Pasterick, North America Health Solutions Leader for Aon, in the release announcing the 2027 figure. “At this level, rising health care costs become much more than a budgeting challenge and influence organizational decisions from benefits strategy and employee affordability to broader workforce and financial planning priorities.” Aon’s own numbers back that framing: employer health spending per employee has risen from 3.7% growth in 2022 to 8.8% in 2026, and the middle 50% of employers it tracks saw increases ranging from 5.5% to 11.5%, a spread wide enough that the median figure understates how severe the pressure is at the high end.
Both surveys also point to the same forecasting problem. BGH’s data, as PlanAdviser reported, shows employers have now underestimated their actual health costs for three consecutive years, with the gap widening each year from 2023 to 2025. That is a different kind of warning than a single high number: it suggests the models employers use to plan their own benefits budgets are structurally biased toward optimism, which makes a 9.2% or 9.5% projection for 2027 more likely to be a floor than a ceiling.
How the Trade Press Read the Same Trend
MedCity News: A Playbook Story
MedCity News led with the BGH numbers and framed the story around what employers are doing in response: about 95% of BGH respondents have issued requests for proposals and 58% plan to replace underperforming vendors. BGH’s executive summary adds that 83% have widened the scope of performance guarantees they demand from health partners. The piece quoted BGH vice president Brenna Shebel on pharmacy: “What this signals to us is that it’s a broader shift towards greater transparency with pharmacy benefits,” and treated the survey primarily as a signal about vendor and plan design strategy heading into 2027.
HR Executive: Vendors on Notice
HR Executive, republishing BenefitsPRO reporting, went further and put the two surveys side by side, noting that BGH’s participants project underlying costs rising 8.8% in 2025, roughly 8.5% this year and about 9.2% next year, while Aon separately puts 2027 growth at 9.5%. Its framing centered on vendor risk: after years of high retention, insurers, PBMs and plan administrators may be about to see clients walk, because employers are now treating cost-management performance as a condition of the relationship rather than a footnote to it.
Chief Healthcare Executive: A Systemic Framing
Chief Healthcare Executive covered the same BGH survey but pushed past the vendor-management angle entirely. Its reporting centered on BGH president and CEO Ellen Kelsay. “This volatility is the new reality,” she said, and “Current forecasts for 2026 and 2027 may actually be too optimistic,” she warned. The piece also quoted her on the drivers behind the number: “Provider consolidation has reduced competition in many markets.” BGH’s executive summary carries detail the HR-focused coverage left out: 64% of employers say AI is driving their costs up through providers’ revenue optimization and upcoding, and 45% already see or expect high volumes of Independent Dispute Resolution claims under the No Surprises Act.
Where the Coverage Disagrees
The three accounts do not contradict each other on the facts, but they disagree on what the facts mean. MedCity News and HR Executive both treat the 2027 numbers as an operational problem: a harder renewal season that calls for more RFPs, tighter vendor scorecards and faster adoption of centers-of-excellence models. Chief Healthcare Executive treats the same numbers as evidence of something structural: that cost growth is now being driven by forces a vendor swap will not fix, such as provider consolidation, AI-assisted upcoding and out-of-network billing disputes. Both readings are defensible from the same release. Neither trade outlet reconciles them, because neither is trying to; each is writing for its own audience’s next decision, not for the shape of the trend across two surveys and three publications.
What It Means for the HR Leader
The through-line the individual stories miss is this: when two employer-health surveys built on different samples land nine months apart in publication cadence but describe the same fourth consecutive year of near-double-digit growth, a better RFP only covers half the response. The operational playbook (tighter vendor scorecards, RFPs, performance guarantees) and the structural one (rethinking what an employer’s role in financing health care even is) run in sequence. The vendor-management moves MedCity News and HR Executive describe buy time. They do not address the drivers Chief Healthcare Executive surfaced, and BGH’s own survey shows employers know it. “Not a single employer will be adding GLP-1 coverage for weight management next year in ’27,” Shebel said, and MedCity News reported that 14% of employers have dropped or will drop GLP-1 coverage in 2027, a retreat that treats a symptom of cost growth rather than a cause.
For benefits and total rewards leaders, the practical read is to treat 2027 planning as a two-track exercise. Track one is the RFP and vendor-accountability work already underway across the industry, worth doing regardless of which survey’s number proves closer to right. Track two is a harder conversation with finance and the C-suite about whether the current employer-sponsored model can keep absorbing 9% annual growth without a change in plan architecture, not just plan vendor. A separate benefits-cost survey published earlier this year found large employers already raising the share of costs shifted to employees rather than closing that data gap, and the same tension shows up again here: activity on the vendor side is outpacing clarity on where the money is actually going.
There is a timing argument buried in the forecasting-miss data too. PlanAdviser quoted Kelsay saying “employers have locked in their budgets and strategies for the next year,” and Chief Healthcare Executive quoted her saying “Many employers won’t have room to make truly transformative moves until 2028 at the earliest,” so the vendor RFPs going out now will not show up as savings until the 2028 plan year even if every one of them succeeds. That means the decisions HR and benefits teams make in the next two renewal cycles are effectively locked in against a cost trend that, per three straight years of misses, is more likely to accelerate than plateau. Budget for 2027 assuming the higher of the two numbers, not the lower one.
The Takeaway
Two surveys agreeing within half a point, in the same fortnight, on a fourth consecutive year of near-double-digit health cost growth is itself the story, more than either number is individually. Trade coverage split that story into an operations piece and a systemic-risk piece because that is how each outlet’s audience consumes it. HR leaders do not have that luxury. Vendor RFPs are necessary and, per BGH, already 95% underway. But the accountability pressure now being placed on plan administrators, described in detail in recent reporting on benefits vendor performance, only closes a small part of the gap between 8% cost growth and flat HR budgets. The planning signal for 2027 is less either figure than the fact that two independent surveys landed on essentially the same figure, for the fourth year running, and neither predicts the trend breaking on its own.
Source: Aon
